Medical and Pharmaceutical Cannabis-based medicine could be used to treat Tourette syndrome: study While there's only limited data on the effects of cannabis in minors, researchers suggest it as an alternative to surgery in severe cases Natalia Buendia CalvilloNovember 3, 2021
Data Cannabis 5th most valuable crop in US, Leafly report shows But weed farmers face barriers to many of the subsidies and services afforded to other agricultural businesses Kathryn TindaleNovember 3, 2021
News New York won’t issue weed licences until 2023: regulator The state's cannabis law allows for sales to start in 2022, but weed stores won't be selling until mid-2023 Kathryn TindaleNovember 2, 2021
Research Toxic metals are leaching into cannabis oil cartridges and users may be inhaling them, study shows But terpenes might be tempering the process Natalia Buendia CalvilloOctober 29, 2021
Business Mike Tyson teams up with Columbia Care for Tyson 2.0 pot brand Columbia Care will produce, distribute and sell the celebrity-backed brand Nick LabaOctober 28, 2021
Canada Cannabis helps manage painful endometriosis symptoms: study Data was collected via the Strainprint app, and is some of the first research of its kind to focus on regulated products Kathryn TindaleOctober 27, 2021
Business First medical cannabis flower hits New York shelves, Curaleaf says The state's cannabis control board announced legislative changes to increase patient access at a meeting Oct. 5 Nick LabaOctober 27, 2021
Canada Nova Scotia legal weed sales up 8% to $27M With an average price per gram of $6.50, its prices are competitive with the illicit market, says the NSLC Kathryn TindaleOctober 26, 2021
Business Metro Vancouver pot producers concerned over ‘ill-considered’ draft emission rules The proposed regulations are based on 'flawed' calculations, and would cause months-long shutdowns to change infrastructure, growers say Nick LabaOctober 25, 2021
International UK Prime Minister to consider reducing legal barriers to psilocybin research Conservative MP and drug policy reform chair Crispin Blunt suggests reclassifying the substance to a less severe category of the country's drug law Natalia Buendia CalvilloOctober 25, 2021